MedTrace Logo

Single and Multiple Doses of HA115 and Food Effect in Healthy Adult Volunteers

NCT03567694 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2021-09-08

No results posted yet for this study

Summary

This is a randomized, double-blind, placebo-controlled Phase 1 study of HA115 capsules administered orally to healthy adult volunteers.

Conditions

Interventions

DRUG

HA115

Test Drug

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Conjupro Biotherapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Study Officials · Conjupro Biotherapeutics, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-10-10
Completion
2022-10-12
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03567694 on ClinicalTrials.gov